drugset / Trial / NCT02705612
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this phase II trial is to determine the feasibility and efficacy of nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable locally advanced cervical cancer.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nimotuzumab | Monoclonal antibody | — | — |
| Background | Cisplatin | Other / unclassified | — | Intravenous |